rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010592,
umls-concept:C0022671,
umls-concept:C0034656,
umls-concept:C0035015,
umls-concept:C0072980,
umls-concept:C0085149,
umls-concept:C0209368,
umls-concept:C0439234,
umls-concept:C0443252,
umls-concept:C0687133,
umls-concept:C0699605,
umls-concept:C1548437,
umls-concept:C1882923
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-1-26
|
pubmed:abstractText |
To reduce long-term nephrotoxic calcineurin inhibitor dosage, adjunctive sirolimus or mycophenolate mofetil (MMF) was used in a 150-patient, randomized, three-armed trial in cadaveric or human leukocyte antigen non-identical living-donor first renal transplant recipients (n=50/group).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
244-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14742989-Adult,
pubmed-meshheading:14742989-Area Under Curve,
pubmed-meshheading:14742989-Biological Availability,
pubmed-meshheading:14742989-Cadaver,
pubmed-meshheading:14742989-Cyclosporine,
pubmed-meshheading:14742989-Drug Interactions,
pubmed-meshheading:14742989-Drug Therapy, Combination,
pubmed-meshheading:14742989-Female,
pubmed-meshheading:14742989-Graft Rejection,
pubmed-meshheading:14742989-Humans,
pubmed-meshheading:14742989-Immunosuppressive Agents,
pubmed-meshheading:14742989-Kidney Transplantation,
pubmed-meshheading:14742989-Living Donors,
pubmed-meshheading:14742989-Male,
pubmed-meshheading:14742989-Middle Aged,
pubmed-meshheading:14742989-Mycophenolic Acid,
pubmed-meshheading:14742989-Sirolimus,
pubmed-meshheading:14742989-Tacrolimus,
pubmed-meshheading:14742989-Time Factors,
pubmed-meshheading:14742989-Tissue Donors
|
pubmed:year |
2004
|
pubmed:articleTitle |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
|
pubmed:affiliation |
Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA. gciancio@med.miami.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|